Furthermore, the inhibition of caspase-4 with Ac-LEVD-CHO also reversed IL-1β upregulation, suggesting that targeting caspase-4 could mitigate neuroinflammation associated with AD and related disorders. This evidence concerns the gene IL1B and Alzheimer disease.